Work

A phase II clinical trial of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor-positive triple-negative breast cancer.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.1069

Authors: Jin Sun Lee-Bitar, Paul Henry Frankel, Susan Elaine Yost, Timothy W. Synold, Norma Martinez, Aileen Tang, Dan Schmolze, Sophia Apple, Arti Hurria, James Ross Waisman, George Somlo, Niki Tank Patel, Mina S. Sedrak, Joanne E. Mortimer, Yuan Yuan

Institutions: City Of Hope National Medical Center, City of Hope

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947377647

Cites:

Cited by: 8

Related to: 10